BIOQUAL, Inc.
BIOQ
$35.20
-$2.31-6.16%
OTC PK
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.35% | 11.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.35% | 11.40% | |||
| Cost of Revenue | -2.41% | 11.07% | |||
| Gross Profit | -89.06% | 14.87% | |||
| SG&A Expenses | -4.61% | 1.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.68% | 9.79% | |||
| Operating Income | -202.41% | 20.91% | |||
| Income Before Tax | -447.76% | 44.82% | |||
| Income Tax Expenses | -446.93% | 44.82% | |||
| Earnings from Continuing Operations | -448.07% | 44.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -448.07% | 44.82% | |||
| EBIT | -202.41% | 20.91% | |||
| EBITDA | -541.67% | 229.89% | |||
| EPS Basic | -448.14% | 44.82% | |||
| Normalized Basic EPS | -447.89% | 44.83% | |||
| EPS Diluted | -448.14% | 45.18% | |||
| Normalized Diluted EPS | -447.89% | 44.83% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||